Commitments and Contingencies (Details Narrative)
|
|
1 Months Ended |
6 Months Ended |
|
Nov. 03, 2020 |
Feb. 27, 2023
USD ($)
|
Oct. 19, 2019 |
Jun. 30, 2023
USD ($)
shares
|
Jun. 30, 2023
EUR (€)
|
Jun. 30, 2022
USD ($)
|
Jun. 30, 2023
EUR (€)
shares
|
| Payments For Future Research And Collobration |
|
|
|
$ 959,406
|
|
|
|
| Aggerate Amount Payable, Description |
under the agreement will be completed by the end of the third quarter 2023 at a total cost to the Company of up to $4.2 million
|
|
|
|
|
|
|
| Payable By Company For Services Rendered |
|
|
|
1,316,023
|
|
|
|
| Accrued compensation expense |
|
|
|
1,069,523
|
|
|
|
| Amount Repayable |
|
|
|
428,669
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
1,285,831
|
|
$ 1,769,335
|
|
| Long-term debt payable |
|
|
|
3,651,691
|
|
|
|
| Grant Repyable |
|
|
|
470,290
|
|
|
|
| First Insurance Funding |
|
$ 356,258
|
|
|
|
|
|
| Fixed Interest Rate |
|
7.42%
|
|
|
|
|
|
| Maturity Date |
|
November 2023
|
|
|
|
|
|
| Principal balance payable |
|
|
|
197,921
|
|
|
|
| Recognized total compensation expense |
|
|
|
724,339
|
|
|
|
| Restricted Stock Units [Member] |
|
|
|
|
|
|
|
| Recognized total compensation expense |
|
|
|
393,663
|
|
|
|
| RSU Vested in 2023 |
|
|
|
195,105
|
|
|
|
| RSU Vested in 2025 |
|
|
|
135,571
|
|
|
|
| Unrecognized compensation expense |
|
|
|
873,837
|
|
|
|
| Performance Based Award [Member] | Vest In 2023 [Member] |
|
|
|
|
|
|
|
| Unrecognized compensation expense |
|
|
|
51,995
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
854,055
|
|
|
|
| Performance Based Award [Member] | Vest In 2024 [Member] |
|
|
|
|
|
|
|
| Unrecognized compensation expense |
|
|
|
134,992
|
|
|
|
| Share-based Payment Arrangement, Noncash Expense |
|
|
|
718,946
|
|
|
|
| Managing Director's Agreement [Member] |
|
|
|
|
|
|
|
| Amount payable |
|
|
|
213
|
|
|
|
| Royalty Payment |
|
|
|
$ 120,095
|
|
|
|
| Royality |
|
|
|
6.00%
|
6.00%
|
|
|
| 2015 Plan |
|
|
|
|
|
|
|
| Stock option granted shares | shares |
|
|
|
1,000,000
|
|
|
1,000,000
|
| Restricted stock option granted shares | shares |
|
|
|
500,000
|
|
|
500,000
|
| In 2018 [Member] | Tamu [Member] |
|
|
|
|
|
|
|
| Debt conversion, Converted instrument, Rate |
|
|
7.50%
|
|
|
|
|
| Additional interest |
|
|
5.00%
|
|
|
|
|
| Equity Interest |
|
|
12.50%
|
|
|
|
|
| Equity interest in Volition Vet |
|
|
|
12.50%
|
12.50%
|
|
|
| 2022 [Member] | Loan Agreement [Member] | Long-term Debt [Member] | First Insurance Funding [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount |
|
|
|
$ 1,000,000.0
|
|
|
|
| Fixed Interest Rate |
|
|
|
6.00%
|
|
|
6.00%
|
| Maturity Date |
|
|
|
July 2026
|
July 2026
|
|
|
| Principal Balance Payable |
|
|
|
$ 973,472
|
|
|
|
| Two Thousand Twenty Two [Member] | Univercity Of Texas MD [Member] |
|
|
|
|
|
|
|
| Additional Cost Of Company |
|
|
|
449,406
|
|
|
|
| Collaborative Obligations Amount Due |
|
|
|
$ 449,406
|
|
|
|
| October 31 2022 [Member] | 2015 Plan |
|
|
|
|
|
|
|
| Restricted stock option granted shares | shares |
|
|
|
1,144,000
|
|
|
1,144,000
|
| Walloon Region Government [Member] | In 2018 [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
| Amount Repayable |
|
|
|
$ 109,133
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
€ 181,500
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
605,000
|
| Grant Repaid By Installments |
|
|
|
over 12 years
|
over 12 years
|
|
|
| Walloon Region Government [Member] | In 2020 [Member] |
|
|
|
|
|
|
|
| Amount Repayable |
|
|
|
$ 234,378
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
278,830
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
929,433
|
| Grant Repaid By Installments |
|
|
|
over 15 years
|
over 15 years
|
|
|
| Walloon Region Government [Member] | In 2020 [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
| Amount Repayable |
|
|
|
$ 99,485
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
148,500
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
495,000
|
| Grant Repaid By Installments |
|
|
|
over 10 years
|
over 10 years
|
|
|
| Walloon Region Government [Member] | In 2010 [Member] |
|
|
|
|
|
|
|
| Amount Repayable |
|
|
|
$ 27,294
|
|
|
|
| Repayment Of Grants | € |
|
|
|
|
|
|
314,406
|
| Terms Of Agreement Description |
|
|
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6.00% royalty on revenue, is equal to twice the amount of funding received
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6.00% royalty on revenue, is equal to twice the amount of funding received
|
|
|
| Grant Receivable | € |
|
|
|
|
|
|
€ 10,500.00
|
| ING [Member] | In 2016 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Maturity Date |
|
|
|
May 2031
|
May 2031
|
|
|
| Fixed Interest Rate On Lease |
|
|
|
2.62%
|
|
|
2.62%
|
| Lease Payable |
|
|
|
$ 467,223
|
|
|
|
| Purchase of property | € |
|
|
|
|
|
|
€ 1,120,000
|
| ING [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
15 years
|
15 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 270,000
|
|
|
| Fixed Interest Rate |
|
|
|
2.62%
|
|
|
2.62%
|
| Maturity Date |
|
|
|
December 2031
|
December 2031
|
|
|
| Principal Balance Payable |
|
|
|
$ 182,670
|
|
|
|
| Namur Invest [Member] | In 2016 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 440,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.85%
|
|
|
4.85%
|
| Maturity Date |
|
|
|
December 2023
|
December 2023
|
|
|
| Total Long-term Debt |
|
|
|
$ 42,553
|
|
|
|
| Namur Invest [Member] | In 2019 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.80%
|
|
|
4.80%
|
| Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
| Total Long-term Debt |
|
|
|
$ 205,545
|
|
|
|
| Namur Invest [Member] | In 2020 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
10 years
|
10 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 830,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.00%
|
|
|
4.00%
|
| Maturity Date |
|
|
|
March 2031
|
March 2031
|
|
|
| Principal Balance Payable |
|
|
|
$ 732,612
|
|
|
|
| Namur Invest [Member] | June 2023 [Member] | Loan Agreement [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 400,000
|
|
|
| Loan Drawn Down Amount | € |
|
|
|
|
|
|
€ 200,000
|
| Fixed Interest Rate |
|
|
|
7.00%
|
|
|
7.00%
|
| Maturity Date |
|
|
|
June 2027
|
June 2027
|
|
|
| Principal Balance Payable |
|
|
|
$ 218,355
|
|
|
|
| SOFINEX [Member] | In 2017 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 1,000,000
|
|
|
| Fixed Interest Rate |
|
|
|
4.50%
|
|
|
4.50%
|
| Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
| Total Long-term Debt |
|
|
|
$ 382,122
|
|
|
|
| Drawn down amount | € |
|
|
|
|
|
|
€ 1,000,000
|
| Namur [Member] | 2022 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
| Fixed Interest Rate |
|
|
|
5.45%
|
|
|
5.45%
|
| Maturity Date |
|
|
|
December 2027
|
December 2027
|
|
|
| Principal Balance Payable |
|
|
|
$ 545,888
|
|
|
|
| University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member] |
|
|
|
|
|
|
|
| Collaborative Obligations Amount Due |
|
|
|
510,000
|
|
|
|
| Collaborative Obligations Amount |
|
|
|
2,550,000
|
|
|
|
| Operating Lease Right of Use Obligations [Member] |
|
|
|
|
|
|
|
| Operating Lease Right-of-use Assets |
|
|
|
530,669
|
|
|
|
| Operating Lease Liabilities |
|
|
|
$ 558,456
|
|
|
|
| Weighted Average Discount Rate |
|
|
|
2.53%
|
|
|
2.53%
|
| Payment Of Lease Liabilities |
|
|
|
$ 126,276
|
|
|
|
| Weighted average remaining lease term |
|
|
|
23 months
|
23 months
|
|
|
| Operating Lease Expense |
|
|
|
$ 127,495
|
|
|
|
| Short Term Lease Costs |
|
|
|
$ 33,426
|
|
|
|
| Namur Innovation and Growth [Member] | In 2021 [Member] | Loan Agreement [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
| Loan Agreement Term |
|
|
|
3 years 5 months 30 days
|
3 years 5 months 30 days
|
|
|
| Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 450,000
|
|
|
| Fixed Interest Rate |
|
|
|
5.00%
|
|
|
5.00%
|
| Maturity Date |
|
|
|
June 2025
|
June 2025
|
|
|
| Total Long-term Debt |
|
|
|
$ 368,474
|
|
|
|